Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

doi:10.7326/0003-4819-157-2-201207170-00459

Paper

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Published Jul 17, 2012 · V. Moyer

Annals of Internal Medicine

2,059

Citations

27

Influential Citations

Full text

Abstract

DESCRIPTION Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer. METHODS The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer. RECOMMENDATION The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.

Highly Cited

Study Snapshot

The USPSTF recommends against PSA-based screening for prostate cancer, citing limited evidence and a lack of clear benefits and harms.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

References

Citations